Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

Heinz Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, Robert J. Mayer, Philip Gold, Philip Stella, Barry Mirtsching, Allen L. Cohn, Andrew W. Pippas, Nozar Azarnia, Zenta Tsuchihashi, David J. Mauro, Eric K. Rowinsky

Research output: Contribution to journalArticle

461 Scopus citations

Fingerprint Dive into the research topics of 'Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines'. Together they form a unique fingerprint.

Medicine & Life Sciences